Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Roy Bannister, PhD
Gilead Sciences, Inc.
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-1166) Obeldesivir clinical dose projection for Marburg virus infection post-exposure prophylaxis
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET